|< 

< 

 

...

21

 

22

 

23

 

24

 

25

 

26

 

27

 

28

 

29

 

30

...

 

 >

 >|

Results 271 - 280 of 926

Drug Market and Public Health Policy

2002 - HLS/02/3

1. Foreword 2. Acknowledgements 3. Executive Summary 4. Speech of the Coordinator of the Italian Project of Technical Assistance to the Ministry of Public Health 5. Speech of the Representative of the Italian Ministry of Foreign Affairs 6. Speech of the Italian Ambassador in Beirut 7. Speech of the Lebanese Minister of Public Health, HEM Sleiman Frangieh 8. Conference Program 9. International...

Acute Flaccid Paralysis Surveillance in Lebanon- year 2002

2002 - HLS/02/4 - Nada Ghosn

A. Context B. Objective C. Material and Method 1. AFP and Poliomyelitis Cases 2. Universal Reporting of AFP and Poliomyelitis Cases 3. AFP Investigation 4. National Expert Group 5. Hospital Weekly Zero Reporting 6. Sentinel Active AFP Surveillance D. Results 1. AFP Investigation Findings 2. AFP Classification 3. Hospital Weekly Zero Reporting 4. AFP Sentinelle Active Surveillance System E....

Measles Surveillance System 2002

2002 - HLS/02/5 - Nada Ghosn- Elianor Sayhoun

Introduction 1. Context 2. Objective 3. Methods Legislation 1. Immediate Reporting 2. Measles Investigation 3. Hospital - Based Zero Reporting 4. Dispensary - Based Zero Reporting Case - Based Measles Investigation 1. Case Definition 2. Investigation 3. Serological Test 4. Data and Specimen Flow for Data and Serum Collection 5. Response Zero Reproting Training Sessions Results 1...

Iodized Salt Program Salt Control in the Market 2001-2002

2002 - HLS/02/6 - Nada Ghosn- Antoine Sarkis

A. Legislation 1. The Law of 1781 2. The Salts Standard 1998: 67228 3. The Inspection B. Market Findings 1. Methods 2. Food Premises Visits 3. Salt Sampling 4. Salt Labeling 5. Salt Testing 6. Salt Laboratory Results 7. Conformity to the Law of 1781 8. Conformity to the LIBNOR Standard 9. Adequacy between the of Laboratory Findings and the Labels C. Salt Producers 1. Registered Salt...

Rapid Study on Prevalence of Creutzfeld Jacob Disease in Lebanon 2001

2002 - HLS/02/7 - Nada Ghosn – Rima Chahoud

Context Objectives Material and Methods Results Discussion Conclusion Thanks

Meningitis Cases in Lebanon- Annual Report-2002

2002 - HLS/02/8 - Nada Ghosn- Chirine Hassounah

1. Context 2. Objective 3. Material and Methods 4. Results 5. Discussion 6. Conclusion 7. Tables 8. Figures

Meningitis Cases in Lebanon Annual Report-2001

2002 - HLS/02/9 - Nada Ghosn – Rima Chahoud

1. Context 2. Objectives 3. Material and Methods 4. Results Demographic Results Clinical Findings CSF Results Blood Results Strain Isolates Follow - Up Prophylaxis for Close Contacts Meningitis Type Meningitis Graphs Meningitis Case Mapping 5. Conclusion 6. Tables 7. Graphs 8. Map

Coronary Surgery Practice in Lebanon

2002 - HLS/02/10

1. Acknowledgments 2. Executive Summary 3. The Needs for Coronary Surgery 4. Coronary Disease and Coronary Surgery in Lebanon 5. Why a Study on Heart-Surgery in Lebanon 6. Answering the Many Questions 7. Provisional Results 8. Preliminary Conclusions Annex 1: Prospective Questionnaire CABG-PTCA (PCI) Annex 2: Retrospective Database CABG-PTCA (PCI) Annex 3: Mednet Data

Epidemiological Review of Selected Diseases, Injuries and Risk Factors in Lebanon: Background Information for the National Burden of Disease Study

2002 - HLS/02/11 - Abla Mehio-Sibai – Iman Nuwayhid

Acknowledgements Forward List of Tables and Figures List of Appendices List of Abbreviations Chapter 1: Introduction A. Background B. Why this Study? Chapter 2: Sources of Mortality Data: Relevance To Lebanon A. Introduction B. Vital Registration C. Sample Registration Systems D. Epidemiologic and Heath Surveys Chapter 3: Mortality in Lebanon: What Do We Know So Far? A...

|< 

< 

 

...

21

 

22

 

23

 

24

 

25

 

26

 

27

 

28

 

29

 

30

...

 

 >

 >|

Results 271 - 280 of 926